{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T23:07:33Z","timestamp":1763507253425,"version":"3.45.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T00:00:00Z","timestamp":1763424000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T00:00:00Z","timestamp":1763424000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Pharos University"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Although several studies have proven that cystic fibrosis (CF) does have a definite impact on oral and dental health, others have demonstrated that it does not. Here, we evaluated children with CF in the Egyptian population based on dental indices, salivary biochemical markers, and lifestyle factors, including diet\/medications, in addition to routine bacteriological assays of plaque and caries specimens. Thirty-three children were classified into two groups: CF children (\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u200918) and non-CF children (\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u200915). Dental indices included DMFT and dmft indices to assess caries prevalence, plaque index (PI), and gingival index (GI) to evaluate periodontal health, along with developmental defects of enamel (DDE). Salivary biochemical markers, such as \u03b1-amylase enzyme, SOD, catalase, TNF-\u03b1, and IL-6, are used to assess oxidative\/inflammatory status. Bacteriological analysis was conducted on oral samples. On comparing CF and non-CF children, salivary biochemical markers showed a significant increase in \u03b1-Amylase (\n                    <jats:italic>p<\/jats:italic>\n                    \u2009&lt;\u20090.001), TNF-\u03b1 (\n                    <jats:italic>p<\/jats:italic>\n                    \u2009&lt;\u20090.001), and IL-6 (\n                    <jats:italic>p<\/jats:italic>\n                    \u2009&lt;\u20090.001), and a significant decrease in SOD (\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.027) and catalase (\n                    <jats:italic>p<\/jats:italic>\n                    \u2009&lt;\u20090.001). However, dental indices did not show any significant increase. Klebsiella spp. and Pseudomonas spp. were significantly higher (\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.026 and\n                    <jats:italic>p<\/jats:italic>\n                    \u2009&lt;\u20090.001, respectively), whereas Streptococcus spp. and Moraxella catarrhalis levels did not differ. In conclusion, oxidative stress and inflammatory response in CF children extend to the oral cavity via saliva. However,\u00a0routine medications appear to mitigate these effects, preventing periodontal alteration development. \u00a0Despite the elevated\u00a0\u03b1-amylase activities, dental caries did not develop because of a low-carbohydrate diet.\n                  <\/jats:p>","DOI":"10.1038\/s41598-025-25373-x","type":"journal-article","created":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T11:03:12Z","timestamp":1763463792000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The role of salivary biochemical markers and dental indices in the assessment of oral health of Egyptian children with cystic fibrosis: an exploratory study"],"prefix":"10.1038","volume":"15","author":[{"given":"Nehal Raid","family":"Salman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Engy Saad","family":"Elkaragy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tamer A.","family":"Al-Shafie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Moustafa A.","family":"Matar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,18]]},"reference":[{"key":"25373_CR1","doi-asserted-by":"publisher","first-page":"S48","DOI":"10.1002\/ppul.27294","volume":"60","author":"SK Kabra","year":"2025","unstructured":"Kabra, S. K. Challenges in the care of cystic fibrosis in low-to\u2010middle income countries. Pediatr. Pulmonol. 60, S48\u2013S50 (2025).","journal-title":"Pediatr. Pulmonol."},{"key":"25373_CR2","doi-asserted-by":"publisher","first-page":"175346662513231","DOI":"10.1177\/17534666251323194","volume":"19","author":"V Terlizzi","year":"2025","unstructured":"Terlizzi, V. & Lopes-Pacheco, M. Cystic fibrosis: new challenges and perspectives beyond elexacaftor\/tezacaftor\/ivacaftor. Ther. Adv. Respir. Dis. 19, 17534666251323194 (2025).","journal-title":"Ther. Adv. Respir. Dis."},{"issue":"3","key":"25373_CR3","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1002\/ame2.12180","volume":"4","author":"Q Chen","year":"2021","unstructured":"Chen, Q., Shen, Y. & Zheng, J. A review of cystic fibrosis: basic and clinical aspects. Anim. Models Experimental Med. 4 (3), 220\u2013232 (2021).","journal-title":"Anim. Models Experimental Med."},{"issue":"3","key":"25373_CR4","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1016\/j.jcf.2020.02.010","volume":"19","author":"WR Hunt","year":"2020","unstructured":"Hunt, W. R., Hansen, J. M. & Stecenko, A. A. Glucose ingestion in cystic fibrosis induces severe redox imbalance: A potential role in diabetes. J. Cyst. Fibros. 19 (3), 476\u2013482 (2020).","journal-title":"J. Cyst. Fibros."},{"issue":"4","key":"25373_CR5","doi-asserted-by":"publisher","first-page":"1952","DOI":"10.3390\/ijms22041952","volume":"22","author":"A Ghigo","year":"2021","unstructured":"Ghigo, A., Prono, G., Riccardi, E. & De Rose, V. Dysfunctional inflammation in cystic fibrosis airways: from mechanisms to novel therapeutic approaches. Int. J. Mol. Sci. 22 (4), 1952 (2021).","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"25373_CR6","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/s41368-023-00231-6","volume":"15","author":"P Dongiovanni","year":"2023","unstructured":"Dongiovanni, P. et al. Salivary biomarkers: novel noninvasive tools to diagnose chronic inflammation. Int. J. Oral Sci. 15 (1), 27 (2023).","journal-title":"Int. J. Oral Sci."},{"issue":"1","key":"25373_CR7","doi-asserted-by":"publisher","first-page":"15991","DOI":"10.1038\/s41598-022-20475-2","volume":"12","author":"C Rinderknecht","year":"2022","unstructured":"Rinderknecht, C. et al. Associations between salivary cytokines and oral health, age, and sex in healthy children. Sci. Rep. 12 (1), 15991 (2022).","journal-title":"Sci. Rep."},{"issue":"7","key":"25373_CR8","doi-asserted-by":"publisher","first-page":"763","DOI":"10.3390\/diagnostics14070763","volume":"14","author":"D-T Anton-P\u0103duraru","year":"2024","unstructured":"Anton-P\u0103duraru, D-T. et al. Diagnosing cystic fibrosis in the 21st Century\u2014A complex and challenging task. Diagnostics 14 (7), 763 (2024).","journal-title":"Diagnostics"},{"issue":"4","key":"25373_CR9","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1007\/s40368-024-00885-8","volume":"25","author":"D Chin","year":"2024","unstructured":"Chin, D., Ramalingam, L., Harrison, J. & Silva, M. Oral health and related outcomes in children and adolescents with cystic fibrosis: a scoping review. Eur. Archives Pediatr. Dentistry. 25 (4), 455\u2013469 (2024).","journal-title":"Eur. Archives Pediatr. Dentistry"},{"issue":"3","key":"25373_CR10","doi-asserted-by":"publisher","first-page":"338","DOI":"10.3390\/antibiotics10030338","volume":"10","author":"G Taccetti","year":"2021","unstructured":"Taccetti, G. et al. Cystic fibrosis: recent insights into inhaled antibiotic treatment and future perspectives. Antibiotics 10 (3), 338 (2021).","journal-title":"Antibiotics"},{"key":"25373_CR11","doi-asserted-by":"publisher","first-page":"103509","DOI":"10.1016\/j.jdent.2020.103509","volume":"103","author":"N Coffey","year":"2020","unstructured":"Coffey, N., O\u2019Leary, F., Burke, F., Roberts, A. & Hayes, M. Periodontal and oral health status of people with cystic fibrosis: a systematic review. J. Dent. 103, 103509 (2020).","journal-title":"J. Dent."},{"issue":"1","key":"25373_CR12","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1186\/s12903-024-04227-4","volume":"24","author":"F O\u2019Leary","year":"2024","unstructured":"O\u2019Leary, F. et al. The prevalence of developmental defects of enamel in people with cystic fibrosis: a systematic review. BMC Oral Health. 24 (1), 446 (2024).","journal-title":"BMC Oral Health"},{"key":"25373_CR13","unstructured":"Rosner, B. Fundamentals of biostatistics: Nelson Education. Nelson Education. (2015)."},{"key":"25373_CR14","unstructured":"G*Power. Universit\u00e4t D\u00fcsseldorf. (2019)."},{"issue":"1","key":"25373_CR15","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1111\/ipd.13216","volume":"35","author":"MA Matar","year":"2025","unstructured":"Matar, M. A. et al. Oral health status of Egyptian children with lysosomal storage diseases: an evaluation of dental indices, salivary cytokines level, and bacterial bioburden. Int. J. Pediatr. Dent. 35 (1), 155\u2013164 (2025).","journal-title":"Int. J. Pediatr. Dent."},{"issue":"12","key":"25373_CR16","doi-asserted-by":"publisher","first-page":"1879","DOI":"10.3390\/children10121879","volume":"10","author":"D-T Anton-P\u0103duraru","year":"2023","unstructured":"Anton-P\u0103duraru, D-T. et al. An update in cystic Fibrosis-Related diabetes in children and adolescents. Children 10 (12), 1879 (2023).","journal-title":"Children"},{"key":"25373_CR17","doi-asserted-by":"crossref","unstructured":"de Moraes, D. A., Lia, \u00c9. N. & J\u00e1come, L. M. T. Cunha CdAP, Monte LdFV. Oral health in individuals with cystic fibrosis: A cross-sectional study. Heliyon ;10(3). (2024).","DOI":"10.1016\/j.heliyon.2024.e25241"},{"issue":"11","key":"25373_CR18","doi-asserted-by":"publisher","first-page":"2839","DOI":"10.1002\/ppul.26145","volume":"57","author":"C Ozsin-Ozler","year":"2022","unstructured":"Ozsin-Ozler, C. et al. Dental caries and associated salivary biomarkers in patients with cystic fibrosis. Pediatr. Pulmonol. 57 (11), 2839\u20132846 (2022).","journal-title":"Pediatr. Pulmonol."},{"issue":"3","key":"25373_CR19","doi-asserted-by":"publisher","first-page":"e379","DOI":"10.4317\/medoral.22756","volume":"24","author":"R Abu-Zahra","year":"2019","unstructured":"Abu-Zahra, R., Antos, N. J., Kump, T. & Angelopoulou, M. V. Oral health of cystic fibrosis patients at a North American center: A pilot study. Medicina oral. Patologia Oral Y Cir. Bucal. 24 (3), e379 (2019).","journal-title":"Patologia Oral Y Cir. Bucal"},{"issue":"4","key":"25373_CR20","doi-asserted-by":"publisher","first-page":"152","DOI":"10.4103\/AMJM.AMJM_47_20","volume":"16","author":"V Ramanarayanan","year":"2020","unstructured":"Ramanarayanan, V. et al. Measuring dental diseases: A critical review of indices in dental practice and research. Amrita J. Med. 16 (4), 152\u2013158 (2020).","journal-title":"Amrita J. Med."},{"key":"25373_CR21","first-page":"725","volume":"129","author":"T Pawlaczyk-Kamie\u0144ska","year":"2019","unstructured":"Pawlaczyk-Kamie\u0144ska, T., Borysewicz-Lewicka, M., \u015aniata\u0142a, R. & Batura-Gabryel, H. Clinical evaluation of the dental hard tissues in an adult population with cystic fibrosis. Pol. Arch. Intern. Med. 129, 725\u2013727 (2019).","journal-title":"Pol. Arch. Intern. Med."},{"issue":"2","key":"25373_CR22","doi-asserted-by":"publisher","first-page":"26","DOI":"10.3390\/oral5020026","volume":"5","author":"V Constantin","year":"2025","unstructured":"Constantin, V. et al. Salivary biomarkers identification: advances in standard and emerging technologies. Oral 5 (2), 26 (2025).","journal-title":"Oral"},{"key":"25373_CR23","doi-asserted-by":"crossref","unstructured":"Priyadarsini, S. S. et al. Salivary alpha amylase as a diagnostic biomarker for dental caries\u2013A systematic review and meta analysis. Arch. Oral Biol. :106136. (2024).","DOI":"10.1016\/j.archoralbio.2024.106136"},{"issue":"10","key":"25373_CR24","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1203\/00006450-197810000-00003","volume":"12","author":"GP Davidson","year":"1978","unstructured":"Davidson, G. P., Koheil, A. & Forstner, G. G. Salivary amylase in cystic fibrosis: a marker of disordered autonomic function. Pediatr. Res. 12 (10), 967\u2013970 (1978).","journal-title":"Pediatr. Res."},{"issue":"11","key":"25373_CR25","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1203\/00006450-198011000-00004","volume":"14","author":"BK Gillard","year":"1980","unstructured":"Gillard, B. K., Simbala, J. A. & Feig, S. A. Serum amylase isoenzymes in cystic fibrosis patients. Evidence for a generalized defect in exocrine gland secretory regulation. Pediatr. Res. 14 (11), 1168\u20131172 (1980).","journal-title":"Pediatr. Res."},{"issue":"1","key":"25373_CR26","doi-asserted-by":"publisher","first-page":"5818840","DOI":"10.1155\/2022\/5818840","volume":"2022","author":"A Almeslet","year":"2022","unstructured":"Almeslet, A., Alnamlah, S., Alanzan, L., Aldriwesh, R. & AlWehaiby, S. Role of salivary biomarkers in cystic fibrosis: a systematic review. Biomed. Res. Int. 2022 (1), 5818840 (2022).","journal-title":"Biomed. Res. Int."},{"issue":"12","key":"25373_CR27","doi-asserted-by":"publisher","first-page":"3080","DOI":"10.3390\/diagnostics12123080","volume":"12","author":"A Alamoudi","year":"2022","unstructured":"Alamoudi, A., Alamoudi, R., Gazzaz, Y. & Alqahtani, A. M. Role of salivary biomarkers in diagnosis and detection of dental caries: a systematic review. Diagnostics 12 (12), 3080 (2022).","journal-title":"Diagnostics"},{"issue":"2","key":"25373_CR28","doi-asserted-by":"publisher","first-page":"927","DOI":"10.3390\/app14020927","volume":"14","author":"P L\u00f3pez-Jornet","year":"2024","unstructured":"L\u00f3pez-Jornet, P. et al. The role of salivary biomarkers in monitoring oral health in patients with implants and periodontitis. Appl. Sci. 14 (2), 927 (2024).","journal-title":"Appl. Sci."},{"issue":"5","key":"25373_CR29","doi-asserted-by":"publisher","first-page":"113","DOI":"10.3390\/dj11050113","volume":"11","author":"E-M Pacheco-Quito","year":"2023","unstructured":"Pacheco-Quito, E-M., Jaramillo, J., Sarmiento-Ordo\u00f1ez, J. & Cuenca-Le\u00f3n, K. Drugs prescribed for asthma and their adverse effects on dental health. Dentistry J. 11 (5), 113 (2023).","journal-title":"Dentistry J."},{"issue":"21","key":"25373_CR30","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.1001\/jama.2023.8120","volume":"329","author":"T Ong","year":"2023","unstructured":"Ong, T. & Ramsey, B. W. Cystic fibrosis: a review. Jama 329 (21), 1859\u20131871 (2023).","journal-title":"Jama"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-25373-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-25373-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-25373-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T23:03:11Z","timestamp":1763506991000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-25373-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,18]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["25373"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-25373-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"type":"electronic","value":"2045-2322"}],"subject":[],"published":{"date-parts":[[2025,11,18]]},"assertion":[{"value":"2 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The Unit of Research Ethics Approval Committee (UREAC) at Pharos University in Alexandria approved this study; serial no. 308\u201329\/12\/2024. Informed consent to participate was received from each child\u2019s parents, either healthy (non-CF) children or children with CF, at the beginning of the study. The study involved patients who complied with the ethical principles outlined in the Declaration of Helsinki in 1964 and its subsequent revisions or updates. All dental examinations of this study were conducted in the dental pediatric clinic, Faculty of Dentistry, Pharos University in Alexandria. All clinical examinations\/investigations were performed at the pediatric clinic, Faculty of Medicine, Alexandria University.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics statement"}}],"article-number":"40373"}}